fact or fiction: is pbpk a substitute for clinical ddi data?
Published 1 year ago • 290 plays • Length 4:22Download video MP4
Download video MP3
Similar videos
-
58:36
pbpk for the pill an approach to assess the risk benefit of drugs
-
47:10
pbpk modelling of prominent oral contraceptive agents and applications in ddi
-
1:00:40
what's new in pbpk & the simcyp simulator
-
49:08
achieving virtual bioequivalence with pbpk in lieu of clinical studies
-
39:17
an introduction to pbpk, simcyp discovery, and the simcyp product suite
-
1:00:48
approaches to address the regulatory requirements for system qualification of the simcyp simulator
-
16:20
certara's simcyp discovery demo
-
2:30
export investigation graphs as pictures from the power quality analysis software quick tip
-
20:15
regulatory requirements for qualifying the simcyp simulator: applications for special populations
-
55:43
pbpk modelling to predict drug-biologic interactions with cytokine modulators
-
14:14
certara's simcyp simulator demo
-
46:25
developing a pbpk model for high lipophilic zwitterionic drugs to predict food effect
-
1:47
simcyp™ pbpk simulator | predicting drug performance
-
1:37:38
human exposure predictions and food effect risk identification using pbpk models
-
2:46
video: fact vs. fiction concerning coronavirus
-
1:53
fact vs. fiction: understanding how covid-19 spreads and who's at risk